Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 18.11% vs 10.43% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 11.46% vs -3.76% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -29.77% vs -3.79% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -2.55% vs 52.22% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Sirio Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 15.48% vs 14.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 18.11% vs 10.43% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 7.27% vs 41.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 11.46% vs -3.76% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -30.63% vs 16.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -29.77% vs -3.79% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 8.54% vs 0.82% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -2.55% vs 52.22% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






